DNA guanine (O6 and N7 positions)

DNA guanine at the O6 and N7 positions serves as a primary molecular target for several classes of cytotoxic chemotherapy, including alkylating agents and platinum-based drugs (PMID: 15507152, 17605361). The N7 atom of guanine is the most nucleophilic site in the DNA structure and is the predominant target for nitrogen mustards and platinum complexes, which often result in DNA cross-links that inhibit replication (PMID: 21114430). The O6 position is a critical target for triazenes like temozolomide and nitrosoureas like carmustine; alkylation here creates O6-methylguanine, which mispairs with thymine during DNA synthesis (PMID: 11134445). This mispairing is recognized by the mismatch repair (MMR) system, but because the template remains damaged, the repair process is futile, leading to persistent strand breaks and the induction of apoptosis (PMID: 15507152). The therapeutic effectiveness of targeting the O6 position is heavily influenced by the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT), which can stoichiometrically remove the alkyl group to restore the base (UniProt: P16455). Consequently, the methylation status of the MGMT gene promoter is a key clinical biomarker used to predict the sensitivity of tumors, particularly glioblastomas, to O6-alkylating therapies (PMID: 15507152).

Other names

O6-guanineN7-guanineGuanine O6Guanine N7DNA alkylation sitesO6-methylguanine siteN7-alkylguanine site

Covalent modification of guanine bases at the O6 or N7 positions, leading to DNA adduct formation, interstrand or intrastrand cross-linking, and induction of apoptosis through DNA damage response pathways.